Upgrade to SI Premium - Free Trial

MaxLinear (MXL) PT Lowered to $90 at Roth Capital

February 3, 2022 4:23 AM
Roth Capital analyst Suji Desilva lowered the price target on MaxLinear (NASDAQ: MXL) to $90.00 (from $100.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles